Unrestricted public coverage is needed for smoking cessation pharmacotherapies.

Kleinman RA, Selby P

Open source

DOI
10.1503/cmaj.231333
Published
2024 Jan 21
Container
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1503/cmaj.231333,
  title = {Unrestricted public coverage is needed for smoking cessation pharmacotherapies.},
  author = {Kleinman RA and Selby P},
  year = {2024},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  doi = {10.1503/cmaj.231333},
  url = {https://doi.org/10.1503/cmaj.231333}
}

RIS

TY  - JOUR
TI  - Unrestricted public coverage is needed for smoking cessation pharmacotherapies.
AU  - Kleinman RA
AU  - Selby P
PY  - 2024
JO  - CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
DO  - 10.1503/cmaj.231333
UR  - https://doi.org/10.1503/cmaj.231333
ER  - 

APA

RA, K., & P, S. (2024). Unrestricted public coverage is needed for smoking cessation pharmacotherapies.. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. https://doi.org/10.1503/cmaj.231333

Source records